Karyopharm Therapeutics (25K0.F) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.98
-3.49
-2.99
-2.5

Details

Expected EPS
-3.008088655
Actual EPS
-3.3157981999999997
Surprise EPS
-0.31
Surprise Percent
+10.23%

Description

Karyopharm Therapeutics (25K0.F) has reported earnings of -3.3157981999999997 per share for Q4 2025.

0 Comments

Share your thoughts